New shoulder implant tracked in 200 patients for lasting relief

NCT ID NCT03547947

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 200 adults who received the Medacta Shoulder System to treat shoulder problems like arthritis, fractures, or to replace a previous implant. Researchers are checking how long the implant lasts, how well the shoulder works, and any side effects. The goal is to confirm the device is safe and effective over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinique du Sport et de Chirurgie Orthopédique

    Marcq-en-Barœul, France

  • Inselspital

    Bern, Switzerland

  • Klinik für Orthopädische Chirurgie und Traumatologie des Bewegungsapparates, Kantonsspital St.Gallen,

    Sankt Gallen, Switzerland

  • Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation

    München, Germany

  • Lindenhofspital

    Bern, Switzerland

  • Orthopädie Sonnenhof

    Bern, Canton of Bern, 3006, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.